Literature DB >> 16614395

Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP.

Renaud Dentin1, Pierre-Damien Denechaud, Fadila Benhamed, Jean Girard, Catherine Postic.   

Abstract

The liver is a major site for carbohydrate metabolism (glycolysis and glycogen synthesis) and triglyceride synthesis (lipogenesis). In the last decade, increasing evidence has emerged to show that nutrients, in particular, glucose and fatty acids, are able to regulate hepatic gene expression in a transcriptional manner. Indeed, although insulin was long thought to be the major regulator of hepatic gene expression, it is now clear that glucose metabolism rather that glucose itself also contributes substantially to the coordinated regulation of carbohydrate and lipid homeostasis in liver. In fact, the recent discovery of the glucose-signaling transcription factor carbohydrate responsive element binding protein (ChREBP) shed some light on the molecular mechanisms by which glycolytic and lipogenic genes are reciprocally regulated by glucose and fatty acids in liver. Here, we will review some of the recent studies that have begun to elucidate the regulation and function of this key transcription factor in liver. Indeed, a better understanding of the mechanisms by which glucose and fatty acids control hepatic gene expression may provide novel insight into the development of new therapeutic strategies for a better management of diseases involving blood glucose and/or disorders of lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614395     DOI: 10.1093/jn/136.5.1145

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  23 in total

1.  Ablation of ghrelin receptor in leptin-deficient ob/ob mice has paradoxical effects on glucose homeostasis when compared with ablation of ghrelin in ob/ob mice.

Authors:  Xiaojun Ma; Yuezhen Lin; Ligen Lin; Guijun Qin; Fred A Pereira; Morey W Haymond; Nancy F Butte; Yuxiang Sun
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

2.  Expression pattern and action analysis of genes associated with the responses to chemical stimuli during rat liver regeneration.

Authors:  Shao-Wei Qin; Li-Feng Zhao; Xiao-Guang Chen; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

Review 3.  Liver steatosis in hepatitis C patients.

Authors:  Emilio González-Reimers; Geraldine Quintero-Platt; Melchor Rodríguez-Gaspar; Remedios Alemán-Valls; Onán Pérez-Hernández; Francisco Santolaria-Fernández
Journal:  World J Hepatol       Date:  2015-06-08

Review 4.  GLUT2, glucose sensing and glucose homeostasis.

Authors:  Bernard Thorens
Journal:  Diabetologia       Date:  2014-11-25       Impact factor: 10.122

5.  Regulation and function of aquaporin-1 in glioma cells.

Authors:  Yasuhiko Hayashi; Nancy A Edwards; Martin A Proescholdt; Edward H Oldfield; Marsha J Merrill
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

6.  Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice.

Authors:  Young-Ah Moon; Robert E Hammer; Jay D Horton
Journal:  J Lipid Res       Date:  2008-10-06       Impact factor: 5.922

7.  n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo.

Authors:  Benjamin Drew Rockett; Muhammad Salameh; Kristen Carraway; Kaitlin Morrison; Saame Raza Shaikh
Journal:  J Lipid Res       Date:  2010-01-13       Impact factor: 5.922

Review 8.  The blind men 'see' the elephant-the many faces of fatty liver disease.

Authors:  Madhusudana Girija Sanal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

9.  Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets.

Authors:  Barbara D Pachikian; Ahmed Essaghir; Jean-Baptiste Demoulin; Audrey M Neyrinck; Emilie Catry; Fabienne C De Backer; Nicolas Dejeans; Evelyne M Dewulf; Florence M Sohet; Laurence Portois; Louise Deldicque; Olivier Molendi-Coste; Isabelle A Leclercq; Marc Francaux; Yvon A Carpentier; Fabienne Foufelle; Giulio G Muccioli; Patrice D Cani; Nathalie M Delzenne
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

10.  Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity.

Authors:  Eungseok Kim; Ning-Chun Liu; I-Chen Yu; Hung-Yun Lin; Yi-Fen Lee; Janet D Sparks; Lu-Min Chen; Chawnshang Chang
Journal:  Diabetes       Date:  2011-04-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.